Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): The road to a success, paved with failures

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): The road to a success, paved with failures
Authors
Keywords
Epidermal growth factor receptor mutation, Non-small cell lung cancer, Tyrosine kinase inhibitor, Resistance mechanism
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 174, Issue -, Pages 1-21
Publisher
Elsevier BV
Online
2017-02-04
DOI
10.1016/j.pharmthera.2017.02.001

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.